Science News from the American Heart Association

We turn American Heart Association's Science News into an interactive format for you. Find something interesting or have a question? Let us know in the comments.

Latest Posts

Science News from ACC 2011: PARTNER

Transcatheter Aortic Valve Implantation versus Surgical Aortic Valve Replacement in “High Risk” Patients with Aortic Stenosis: The Randomized PARTNER Trial
Craig R. Smith, MD on behalf of the PARTNER Trial Investigators, Columbia University, New York, NY

Posted by Molly AHA Science on Apr 3, 2011 1:24 PM CDT

Comments (0)

BASKET PROVE

Late Cardiac Death And Myocardial Infarction Associated With Late Stent Thrombosis In Large Vessel Stenting After 1st Or 2nd Generation Drug-eluting Compared To Bare-metal Stents: the BASKET PROspective Evaluation Examination (BASKET PROVE)

Presenter: Christoph A. Kaiser, University Hospital, Basel

News release below as well as video and links to supporting documents.

* * *
more...

Posted by Stacy AHA Science on Nov 17, 2010 2:20 PM CST

Comments (0)

TAMARIS

NV1FGF Gene Therapy on Amputation-Free Survival in Critical Limb Ischemia - Phase 3 Randomized Double-Blind Placebo-Controlled Trial

Presenter: William R. Hiatt, University of Colorado Denver

A summary is below as well as links to supporting documents.

* * *
more...

Posted by Stacy AHA Science on Nov 17, 2010 8:35 AM CST

Comments (0)

ACT

Acetylcystein for the Prevention of Contrast-Induced nephropaThy (ACT) Trial: a Pragmatic Multicenter Randomized Trial to Evaluate the Efficacy of Acetylcysteine for the Prevention of Renal Outcomes in Patients Undergoing Coronary and Vascular Angiography

Presenter: Otavio Berwanger, Sao Paulo Cardiac Hospital

See below for the news release and links to supporting documents. What do you think?

* * *
more...

Posted by Stacy AHA Science on Nov 16, 2010 7:43 PM CST

Comments (0)

GRAVITAS

Standard Versus High-Dose Clopidogrel According to Platelet Function Testing After PCI: Results of the GRAVITAS Trial

Presenter: Matthew J. Price, Scripps Clinic

We will include the abstract below as well as links to supporting documents.

* * *
more...

Posted by Stacy AHA Science on Nov 16, 2010 3:52 PM CST

Comments (0)

ROCKET AF

Stroke Prevention Using the Oral Direct Factor Xa inhibitor Rivaroxaban Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation (ROCKET AF)

Presenter: Kenneth Mahaffey, Duke University

We will include the abstract below as well as links to supporting documents.

* * * more...

Posted by Stacy AHA Science on Nov 16, 2010 12:04 AM CST

Comments (0)

SMART AV

Scientific Sessions: Science News: Placeholder Image

Primary Results from the SMART AV Trial: A Randomized Trial Comparing Empiric, Echocardiographic Guided and Algorithmic AV Delay Programming in Cardiac Resynchronization Therapy (CRT)

Presenter: Kenneth A. Ellenbogen, Medical College of Virginia

See the news release below as well as links to supporting documents.

* * *
more...

Posted by Stacy AHA Science on Nov 15, 2010 11:53 PM CST

Comments (0)

Fish Oil for AF

Efficacy And Safety Of Prescription Omega-3-Acid Ethyl Esters (P-OM3) For The Prevention Of Recurrent Symptomatic Atrial Fibrillation (AF)

Peter R. Kowey, Lankenau Hospital

We will include the abstract below as well as links to supporting documents.

* * *
more...

Posted by Stacy AHA Science on Nov 15, 2010 11:41 PM CST

Comments (0)

CLOSURE I

CLOSURE I: A Prospective, Multicenter, Randomized Controlled Trial to Evaluate the Safety and Efficacy of the STARFlex® Septal Closure System Versus Best Medical Therapy in Patients with a Stroke or Transient Ischemic Attack due to Presumed Paradoxical Embolism through a Patent Foramen Ovale

Anthony Furlan, University Hospital

The news release is below along with links to supporting documents.

* * *
more...

Posted by Stacy AHA Science on Nov 15, 2010 11:08 PM CST